Clinical trial

Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of Schizophrenia

NCT01738698

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2012-11-01

PhasePHASE3

Study timeline

Study start (actual)2012-11-01Date precision: day

Registry last updated2021-06-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

SPD489 40mgDRUG

SPD489 100mgDRUG

SPD489 160mgDRUG

PlaceboDRUG

Sponsors & collaborators

Shirelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01738698 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.